Bone scintigraphy in evaluation of Didronel therapy for Paget's disease.
A case of advanced Paget's disease was successfully treated with Didronel. All indicators of disease activity have been in remission for two years post-therapy. Although sequential radiographs obtained before and after treatment showed slight changes that might have reflected a reparative process, bone scintigraphs revealed more prominent changes, so that radionuclide bone imaging could well be considered as the follow-up imaging study of choice after treatment of Paget's disease.
D001842:Bone and Bones / Q000000981:diagnostic imaging*; D004164:Diphosphonates; D012968:Etidronic Acid / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D010001:Osteitis Deformans / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011859:Radiography; D011877:Radionuclide Imaging; D013667:Technetium; D013669:Technetium Tc 99m Medronate
D004164:Diphosphonates; D013667:Technetium; D012968:Etidronic Acid; D013669:Technetium Tc 99m Medronate